Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate - Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate
Navigation: NDC > Supplier starting with: C > CARACO PHARMACEUTICAL LABORATORIES, LTD.| Field | Value |
|---|---|
| NDC Code: | 57664-645 |
| Proprietary Name: | Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate |
| Suffix: | |
| Non-Proprietary Name: | Dextroamphetamine saccharate, Amphetamine aspartate, Dextroamphetamine sulfate, and Amphetamine sulfate |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 09-09-2003 |
| Category Name: | ANDA |
| Application Number: | ANDA040480 |
| Labeler: | CARACO PHARMACEUTICAL LABORATORIES, LTD. |
| Substance Name: | AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE |
| Active Numerator Strength: | 3.75; 3.75; 3.75; 3.75 |
| Active Ingredient Unit: | mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
| DEA Schedule: | CII |